BBC News | Health | World Edition
Brain probe hope for epileptics
|
|
A US study says electrical deep brain stimulation is a promising therapy for epileptics who do not respond to drug treatment.
|
|
03/18/2010 05:00 AM
|
|
Hypnotherapy 'can help gut pain'
|
|
Use of hypnotherapy to ease irritable bowel syndrome could help patients and might save money, says an expert.
|
|
03/18/2010 12:49 AM
|
|
Impotence 'link to heart death'
|
|
Impotence is a strong predictor of heart attack and death among high risk patients, say German researchers.
|
|
03/16/2010 12:00 AM
|
|
Women seek neck muscle 'lip job'
|
|
The latest offering in cosmetic surgery for those seeking a fuller pout is a neck muscle lip graft, say US experts.
|
|
03/16/2010 12:00 AM
|
|
Early balding 'cuts cancer risk'
|
|
Men who start going bald at a young age are up to 45% less likely to get prostate cancer in later life, a study has found.
|
|
03/16/2010 12:12 PM
|
|
No quick fix for diabetes risk
|
|
Exercise and diet are key to prevent diabetes, say researchers who found two drug treatments offer no benefit.
|
|
03/15/2010 12:01 AM
|
|
Gum disease 'link' to early birth
|
|
Successful treatment for gum disease cuts the risk of pregnant women giving birth early, say US researchers.
|
|
03/14/2010 12:29 AM
|
|
Obese drinkers face 'double hit'
|
|
Obese women drinking little more than a glass of wine a day have double the risk of liver disease, experts warn.
|
|
03/13/2010 12:09 AM
|
|
New blood pressure approach urged
|
|
Occasionally high blood pressure may be a greater indicator of stroke risk than consistently high readings, researchers say.
|
|
03/12/2010 12:02 AM
|
|
Women on pill 'may live longer'
|
|
Women who took the contraceptive pill are less likely to die of cancer and heart disease, a long-term study has found.
|
|
03/12/2010 07:38 AM
|
|
Home 'cervical cancer' test hope
|
|
At-home screening tests for the virus responsible for most cervical cancers could detect many more cases, say researchers.
|
|
03/12/2010 12:02 AM
|
|
US agrees 9/11 dust payout
|
|
New York City agrees to pay up to 657m US Dollars (437m Sterling) to thousands of rescue and clean-up workers at the 9/11 attacks site.
|
|
03/12/2010 09:15 AM
|
|
|
Health News from Medical News Today
Preoperative Criteria To Select Patients For Bilateral Nerve Sparing Robotic-Assisted Radical Prostatectomy (RALP)
|
|
UroToday.com - Erectile dysfunction is one of the most relevant functional complications following radical prostatectomy. No study had analyzed the predictors of potency recovery in a series of patients undergoing robot-assisted laparoscopic radical prostatectomy (RALP). Moreover, Briganti et al. recently evaluated the recovery of erectile function following retropubic radical prostatectomy, identifying three different risk groups...


|
|
03/18/2010 11:00 AM
|
|
Protalix Initiates A Phase I Clinical Trial Of Acetylcholinesterase For Biodefense Indications
|
|
Protalix BioTherapeutics, Inc. (NYSE-Amex: PLX) announced that it has initiated a phase I clinical trial of PRX-105, the Company's plant cell expressed pegylated recombinant human acetylcholinesterase product candidate in development for biodefense indications. The trial is designed to study the safety of PRX-105 by administering a bolus intravenous injection of PRX-105 in healthy volunteers. The U.S...


|
|
03/18/2010 11:00 AM
|
|
FDA Approves First Totally Implanted Hearing System
|
|
The U.S. Food and Drug Administration announced the approval of the Esteem an implanted hearing system used to treat moderate to severe sensorineural hearing loss, a type of permanent hearing loss. Sensorineural hearing loss is usually caused by genetic factors or damage to the inner ear resulting from noise, viral infections, or aging. The results are reductions in perception of sounds and in the ability to understand speech. This differs from conductive hearing loss, which occurs when sound waves cannot transmit well through the outer or middle ear or both...


|
|
03/18/2010 11:00 AM
|
|
FDA Advisory Committee Recommends Approval Of InterMune's Esbriet(R) (pirfenidone) For Idiopathic Pulmonary Fibrosis
|
|
InterMune, Inc. (Nasdaq: ITMN) announced that the U.S. Food and Drug Administration's (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) voted 9-3 to recommend approval of Esbriet® (pirfenidone) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function. IPF is a rare and fatal lung disease that affects approximately 200,000 people in the United States and Europe. If approved by the FDA for commercialization, Esbriet would be the first medication to be made available to IPF patients in the United States...


|
|
03/18/2010 11:00 AM
|
|
HRSA Study Finds Nursing Workforce Is Growing And More Diverse
|
|
The number of licensed registered nurses (RNs) in the United States grew to a new high of 3.1 million between 2004 and 2008 according to a report released today by the Health Resources and Services Administration (HRSA). This increase of more than 5 percent also reflects growing diversity in the backgrounds of nurses in the United States. "We are encouraged by growth in the numbers and diversity of Registered Nurses, and HRSA is committed to continuing this trend to ensure an adequate supply and distribution of nurses in the future," said HRSA Administrator and nurse Dr. Mary K. Wakefield...


|
|
03/18/2010 11:00 AM
|
|
Carefusion Launches New Device To Help Treat Spinal Fractures
|
|
CareFusion (NYSE: CFN), a leading, global medical device company, announced the launch of the AVAmax® Vertebral Balloon, a minimally invasive device for use during kyphoplasty, a procedure for treating spinal compression fractures. CareFusion is the only company in the industry to offer a full line of products that address both vertebroplasty and balloon kyphoplasty, the two primary approaches to treat spinal compression fractures by delivering bone cement into the vertebral space with specialized needles. CareFusion is currently a market leader in devices for vertebroplasty procedures...


|
|
03/18/2010 11:00 AM
|
|
Radiation Breakthrough Gives Breast Cancer Patients Hope In Single Dose
|
|
Technology never before offered in the U.S. that allows patients to receive one dose of radiation during surgery, as opposed to the current average of six weeks, was successfully delivered to several breast cancer patients last week including the sister of the man responsible for bringing the technology from Italy...


|
|
03/18/2010 11:00 AM
|
|
GenVault Provides GenTegra(TM) DNA To Support Cardiovascular Genetic Testing At Berkeley HeartLab
|
|
GenVault Corporation announced that Berkeley HeartLab, a subsidiary of Celera Corporation (Nasdaq: CRA), has adopted GenTegra DNA to preserve and store diagnostic samples for genetic testing related to the management of cardiovascular disease. As new clinically important diagnostic genetic markers are introduced, such as KIF6 and LPA, accessing stored DNA eliminates the need to collect a new sample and facilitates return of potentially critical medical information back to the physician. Currently, Berkeley HeartLab offers 39 individual clinical laboratory tests...


|
|
03/18/2010 11:00 AM
|
|
ALS Therapy Development Institute And Aestus Therapeutics, Inc. Collaborate To Investigate Potential Treatments For ALS
|
|
The ALS Therapy Development Institute (ALS TDI) and Aestus Therapeutics, Inc., announced their plans today to test several potential small-molecule compounds to slow or stop the progression of Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig's disease). "Aestus is a key, strategic drug discovery partner in the effort to identify potential therapeutics for ALS. This collaborative effort will substantially increase our ability to identify several new existing compounds related to the information gained through our gene expression profiling and proteomics efforts...


|
|
03/18/2010 11:00 AM
|
|
New Data Indicate Effectiveness Of Clarient's Ovotax(TM) Test For Ovarian Cancer
|
|
Clarient, Inc. (Nasdaq: CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, announced that data from a new study shows that Clarient's Ovotax™ assay may effectively predict which ovarian cancer patients will respond favorably to taxane therapy and could, therefore, be spared the potential side effects of this rigorous and sometimes toxic chemotherapy agent. The study was presented yesterday at the national meeting on Women's Cancer of the Society of Gynecologic Oncologists by Janelle Fauci, M.D...


|
|
03/18/2010 11:00 AM
|
|
Dems Defend Health Reform Strategy; Undecided House Members Face Pressure As Vote Nears
|
|
Democratic leaders on Tuesday defended their possible use of a legislative maneuver that would allow House Democrats to pass the Senate health reform bill (HR 3590) in the chamber without members actually having to vote on it, the Washington Post reports. Under this maneuver -- known as a self-executing rule or "deem and pass" -- House Democrats would craft a rule for debate on the budget reconciliation bill that would deem the Senate bill as "passed" upon approval of the budget reconciliation bill, thereby avoiding the need to vote on the Senate bill (Goldstein, Washington Post, 3/17)...


|
|
03/18/2010 11:00 AM
|
|
Neb. Governor's Opposition Could Dim Chances For Prenatal Care Bill
|
|
Nebraska state Sen. Kathy Campbell on Tuesday said that she is abandoning a compromise bill that would temporarily continue state-funded prenatal care to about 1,500 low-income women -- including undocumented immigrants -- because of opposition from Gov. Dave Heineman (R), the AP/Pennsylvania Times Herald reports. Campbell, a key lawmaker in the debate, said that legislators' support for the compromise largely depended on Heineman's stance. Heineman has opposed the effort because it would provide services to undocumented immigrants...


|
|
03/18/2010 11:00 AM
|
|
|
Y! Health News Search RSS Feed
WHO suspends Shan5 combination vaccine (AFP)
|
|
AFP - The World Health Organisation said Thursday it was suspending the use of the Indian-developed Shan5 combination vaccine, which is used against infections such as diphtheria, tetanus and hepatitis B.
|
|
03/18/2010 10:09 AM
|
|
UK, Spain close to approving GW's cannabis drug (Reuters)
|
|
Reuters - A pioneering -- but much delayed -- cannabis-based medicine for multiple sclerosis is now on track to win regulatory approval in Britain and Spain in the second quarter of 2010, its maker said on Thursday.
|
|
03/18/2010 10:07 AM
|
|
Calif. considers smoking ban at all state parks (AP)
|
|
AP - California lawmakers on Thursday will consider what is believed to be the nation's most far-reaching smoking ban in state parks as a way to get unsightly cigarette butts off the beach, eliminate second-hand smoke and reduce the threat of wildfires.
|
|
03/18/2010 09:59 AM
|
|
Safety board to weigh requiring condoms in porn (AP)
|
|
AP - Condoms might be the only thing porn actors are required to wear if the state's workplace safety board approves a petition mandating their use.
|
|
03/18/2010 08:57 AM
|
|
Roche aiming to launch 6 new products by end of 2014 (Reuters)
|
|
Reuters - Roche Holding AG is aiming to launch at least six new products by the end of 2014 and its seeking to strengthen its position in areas outside oncology, the Swiss drugmaker said ahead of its investor day.
|
|
03/18/2010 08:02 AM
|
|
Asthma relief in Pakistan salt mine (AFP)
|
|
AFP - A centuries-old salt mine in Pakistan is offering experimental asthma therapy, attracting patients from all over the world.
|
|
03/18/2010 07:57 AM
|
|
Asthma relief in Pakistan salt mine (AFP)
|
|
AFP - A centuries-old salt mine in Pakistan is offering experimental asthma therapy, attracting patients from all over the world.
|
|
03/18/2010 07:48 AM
|
|
China orders probe after unsafe vaccine report (AFP)
|
|
AFP - China has ordered an investigation after a report that unsafe vaccines led to the deaths of four children and sickened 74 others in the country's latest product-quality scare.
|
|
03/18/2010 06:44 AM
|
|
China says probing report on deadly faulty vaccines (Reuters)
|
|
Reuters - China's Health Ministry is probing a report in a domestic newspaper that faulty vaccines in northern Shanxi province were responsible for killing four children and making dozens of others sick.
|
|
03/18/2010 04:23 AM
|
|
Could Lowering Blood Pressure Help Stop Dementia? (HealthDay)
|
|
HealthDay - WEDNESDAY, March 17 (HealthDay News) -- In the ongoing struggle to find
treatments -- and maybe one day even a cure -- for dementia, researchers
are focusing their attention on high blood pressure, long a culprit for a
variety of other ills and an ailment for which many drugs are already
available.
|
|
03/18/2010 03:49 AM
|
|
|